Maze Therapeutics Inc (NAS:MAZE)
$ 24.69 +0.070 (+0.28%) Market Cap: 1.37 Bil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 3.02 GF Score: 16/100

Maze Therapeutics, Inc. at Citi Biopharma Back to School Summit Transcript

Sep 10, 2026 / 06:20 PM GMT
Release Date Price: $24.82 (+0.98%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MAZE.OQ - Maze Therapeutics, Inc.
Maze Therapeutics, Inc. at Citi Biopharma Back to School Summit
Sep 10, 2026 / 06:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to day two of Citi's Back to School Biopharma Conference. I'm Eric Joseph, senior biotech analyst with the firm, and our session now is with Maze Therapeutics. It's my pleasure to have with us CFO Mizbah Tahir to talk to us about the company.

Mizbah, thanks for joining us today. Maybe just for those less familiar with the company and the webcast, it would be useful to have you kind of provide us with a brief snapshot of the company. And what some of Maze's key objectives are over the next 12 to 18 months.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot